Radiation InjuriesRadiation DosageAntineoplastic Combined Chemotherapy ProtocolsRadiation, IonizingAntineoplastic AgentsDose-Response Relationship, RadiationCombined Modality TherapyRadiotherapyRadiation ToleranceRadiotherapy DosageChemotherapy, AdjuvantRadiationTreatment OutcomeRadiation OncologyRadiation ProtectionRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation MonitoringCisplatinRadiotherapy, AdjuvantDoxorubicinDose FractionationNeoplasmsRadiation PneumonitisRadiotherapy Planning, Computer-AssistedBreast NeoplasmsBrachytherapyCell Line, TumorNeoplasm StagingNeoplasm Recurrence, LocalDisease-Free SurvivalRadiation-Sensitizing AgentsSurvival AnalysisRadiometryNeoplasms, Radiation-InducedBrain NeoplasmsTime FactorsSurvival RateRadiation Injuries, ExperimentalRadiosurgeryDrug Screening Assays, AntitumorPrognosisEtoposideGamma RaysFollow-Up StudiesCyclophosphamideLung NeoplasmsCranial IrradiationDrug Resistance, NeoplasmCosmic RadiationHead and Neck NeoplasmsNeoadjuvant TherapyApoptosisPaclitaxelRadiotherapy, Computer-AssistedAntineoplastic Agents, PhytogenicRetrospective StudiesAdenocarcinomaCarcinoma, Squamous CellParticle AcceleratorsCell SurvivalRadiotherapy, Image-GuidedRadiation-Protective AgentsRadiotherapy, High-EnergyTomography, X-Ray ComputedRadiodermatitisDrug Administration ScheduleChemoradiotherapyAntibiotics, AntineoplasticBackground RadiationVinblastineCarboplatinBleomycinProspective StudiesProstatic NeoplasmsDNA DamageCarcinoma, Non-Small-Cell LungAntineoplastic Agents, AlkylatingAntimetabolites, AntineoplasticDacarbazineMethotrexateUltraviolet RaysOrgans at RiskXenograft Model Antitumor AssaysMice, NudeMastectomy, SegmentalCobalt RadioisotopesTumor BurdenTumor Cells, CulturedClinical Trials as TopicHodgkin DiseaseDose-Response Relationship, DrugRadiation EffectsCamptothecinNeoplasm MetastasisActuarial AnalysisOrganoplatinum CompoundsDeoxycytidinePostoperative ComplicationsFluorouracil